NIH-funded research R01 grant

Understanding genetic networks in autism and bipolar disorders to improve biology and treatment

Official title: Delineating the network effects of mental disorder-associated variants using convex optimization methods

Funded at New York Genome Center · NIH-11352565 · Data updated 2026-11-12

A research grant will study how genetic factors influence autism and bipolar disorder by using advanced math and large genetic datasets to map networks in the brain.

More Mental Disorder research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York Genome Center
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$773,033
NIH project number5R01MH130879-05
Project IDNIH-11352565 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals diagnosed with autistic disorder or bipolar disorder who have available genetic data and consent for research use.

Less likely to help

People without these conditions or without access to genetic data for research may not directly benefit.

What this research studies

This project uses big genetic data from people with autism and bipolar disorder to identify how genes interact and contribute to disease risk. It will apply new convex optimization methods to find shared and distinct genetic components across conditions and to map gene regulatory networks in the brain. The goal is to uncover clearer biological pathways that could eventually inform new approaches to prevention and treatment. Results will come from collaborations with international groups and will emphasize reproducible analysis across diverse populations.

Why it matters

Potential benefit: If successful, the work could reveal key genetic pathways that underlie autism and bipolar disorder, guiding future therapies and personalized care.

How similar studies have gone: Similar large-scale genetic studies have identified polygenic patterns; this project builds on established methods with a novel multi-trait and network-focused approach.

Where this research is happening

  • New York Genome Center
    New York, United States
    Active

Researchers

  • Principal investigator: Knowles, David Arthur — New York Genome Center
  • Study coordinator: Knowles, David Arthur

Related research

Other NIH-funded projects on the same topics.

  • Understanding genetic factors in mental disorders using advanced algorithms

    This study is looking at the genes linked to conditions like autism and bipolar disorder to help us understand what makes them happen, which could lead to better treatments for people living with these challenges.

    NIH research New York Genome Center · New York, United States · NIH-11093320

  • Virtual approaches for period pain in young women

    This study tests two online self-care options—auricular acupressure and Baduanjin qigong—against a self-care education group to see if they reduce menstrual pain and related symptoms in young women.

    Recruiting Phase 2/3 Nanyang Technological University · Singapore · NCT07497711

  • Outcomes of Strategic Psychotherapy for Adults in Private Practice

    This project will see if brief Strategic Psychotherapy helps adults with diagnosed mental disorders who seek private outpatient care improve symptoms and everyday functioning.

    Recruiting at 2 sites Società Scientifica di Psicoterapia Strategica · Empoli, Italy and 1 other locations · NCT07195266

  • Connectivity-guided theta-burst stimulation targeting the hippocampus in schizophrenia

    We will try targeted theta-burst TMS guided by brain connectivity to change hippocampus activity in adults with schizophrenia or related psychotic disorders, measuring brain signals with EEG and, for some participants, intracranial electrodes.

    Recruiting Stanford University · Stanford, California · NCT07010614

  • Genetic-guided psychotropic medication choices for adults in Manitoba

    This project will test whether using a patient's genetics to guide psychotropic medication choices helps adults in Manitoba who are starting or changing psychiatric medicines.

    Recruiting University of Manitoba · Winnipeg, Manitoba and 1 other locations · NCT06929533

  • Digital program to reduce depression and cannabis use

    This trial will test a digital program called AMP-C to see if it reduces depressive symptoms and cannabis use in adults with both major depression and problematic cannabis use.

    Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT06878859

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.